Company profile: Arch Therapeutics
1.1 - Company Overview
Company description
- Provider of medical devices for stasis and barrier applications, focusing on wound management and hemostasis, including AC5 Advanced Wound System to promote hemostasis and seal wounds and AC5 Topical Hemostat for bleeding control in surgical, trauma, and interventional care; plus investigational products AC5-G, AC5-V, and AC5 Surgical Hemostat.
Products and services
- AC5 Advanced Wound System: A barrier-forming medical device engineered for wound management, facilitating faster and safer care by promoting hemostasis and sealing wounds
- AC5 Surgical Hemostat: An investigational-use device designed to control bleeding and manage wounds in surgical settings, currently not available for commercial use
- AC5 Topical Hemostat: A topical device intended for controlling bleeding, delivering hemostasis during surgical, trauma, and interventional care
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Arch Therapeutics
Medical Modeling
HQ: United States
Website
- Description: Provider of 3D printing-centric personalized surgical treatments and patient-specific medical devices, offering commercial 3D printers, 3D printing materials (plastic, elastomer, composite, wax, metal, bio-compatible), AI-powered additive manufacturing software for industrial and healthcare, consultative services via an Application Innovation Group, and aerospace/defense solutions including lightweight parts, passive RF hardware, propulsion components, and 3D-printed heat exchangers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medical Modeling company profile →
Ceterix
HQ: United States
Website
- Description: Provider of novel surgical tools for arthroscopic procedures, enabling surgeons to place stitches in tight joint compartments while protecting surrounding structures such as nerves, arteries and cartilage. Products include the NovoStitch Plus Meniscal Repair System for repairing complex meniscal tears, including horizontal, radial, and root tears often left untreated or treated by meniscectomy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ceterix company profile →
Mellon Medical
HQ: The Netherlands
Website
- Description: Provider of suturing tools and surgical instruments for surgeons, enabling single-handed stitching for efficient, effective suturing. Offers the Switch® one-handed suturing device, the Small-bites suturing technique for abdominal wall closures, and the Switch-Aid® needle loader for safe, comfortable suture loading, helping improve precision and patient outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mellon Medical company profile →
Pluromed
HQ: United States
Website
- Description: Provider of disposable medical devices based on reverse thermosensitive polymer technology. Develops, manufactures, and markets products in Europe, Canada, and the United States, including LeGoo Internal Vessel Occluder (a liquid polymer for the temporary occlusion of blood vessels) and LeGoo Endovascular Occlusion Gel.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pluromed company profile →
EndoVia Medical
HQ: United States
Website
- Description: Provider of physician-guided robotic systems for minimally invasive surgery, including the Laprotek robotic instrument system for procedures in general surgery, urology, gynecology, and bariatric surgery, and the ViaCath user interface and instrument control platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EndoVia Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Arch Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Arch Therapeutics
2.2 - Growth funds investing in similar companies to Arch Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Arch Therapeutics
4.2 - Public trading comparable groups for Arch Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →